UT Southwestern Medical Center
Dallas, Texas, 75235, United States
NCT Number: NCT07720713
This investigation assesses the impact of a strengthening program on muscle metabolism in the gastrocnemius muscle (GM) and is an essential step in the establishment of future clinical intervention for the GM in people with Parkinson's disease (with healthy peers as the control group). The participants will be provided with a progressive GM strengthening program while monitoring muscle metabolism and functional changes before and after intervention.
Looking for future studies?
Notify Me50 year–80 year
All sexes
Interventional
Not applicable
Dallas, Texas, 75235, United States
This is a repeated measures study with a total of 20 participants (15 individuals with varying PD severity and 5 age matched controls). Strength, functional ability, and metabolic properties (MRS) of the GM will be measured on participants before and after a 4 week progressive strengthening program for the GM. The program is designed to utilize high volume exercise to account for unique properties of the GM (2 sets of heel raises to fatigue, 3 times a week). Loading will be individualized and progressed based on participant strength. There will be contact for accountability/direction on exercise progression. Demographic data including sex, age, medications, and years since disease onset will be collected.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All participants completed a four-week, home-based progressive strengthening program targeting GM using high-volume bodyweight exercise. Participants were instructed to perform exercises three times per week, with at least one day of rest between exercise sessions.
During weeks 1 and 2, participants performed two sets of heel raises to fatigue at their prescribed level, corresponding to a subjective effort rating of 8/10. The goal was to progress toward completing 20 repetitions per set. Exercise loading was individualized based on baseline performance and adjusted throughout the intervention according to each participant's demonstrated strength progression.
Time frame: Day 1 (baseline) and 4 weeks (post exercise program)
A non-invasive measure of metabolites and their dynamics in resting and activated human muscles to explores how well muscle handles its ATP energy demands.
Time frame: Day 1 (baseline) and 4 weeks (post exercise program)
Clinical measure of gastrocnemius strength, tested unilaterally, using the Calf -Raise Senior Test with a stadiometer for objective heel raise strength.
University of Texas Southwestern Medical Center
Other
Assessment of Muscle Metabolism Using Magnetic Resonance Spectroscopy With Clinical Strengthening in Parkinson's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07148700
Basal Ganglia Diseases, Brain Diseases
Istanbul, Eyup, Turkey (Türkiye)
View Trial DetailsNCT06037590
Basal Ganglia Diseases, Brain Diseases
Sofia, Bulgaria
View Trial DetailsNCT06892418
Basal Ganglia Diseases, Behavior
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05596201
Basal Ganglia Diseases, Brain Diseases
Nijmegen, Gelderland, Netherlands
View Trial Details